Feedback / Questions
AP 402 - AP Biosciences
https://www.globenewswire.com/news-release/2025/04/22/3065502/0/en/AP-Biosciences-Doses-First-Patient-in-Phase-1-2-Clinical-Trials-of-AP402-for-HER2-Cancer-Patients.html
Apr 22, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next